A nonenzymatic reaction between reducing sugars and amino groups of proteins results in
the formation of advanced glycation end products, which are linked to a number of chronic …

In diabetes mellitus, hyperglycemia mediated non-enzymatic glycosylation of proteins
results in the pathogenesis of diabetes-associated secondary complications via the …

The process of glycation, characterized by the non-enzymatic reaction between sugars and
free amino groups on biomolecules, is a key contributor to the development and progression …

Non-enzymatic glycation occurs rapidly which ultimately leads to the formation of advanced
glycation endproducts (AGEs). These AGEs have shown to associated with the development …

Glycation of biologically important macromolecules leads to the establishment of advanced
glycation end products (AGEs) having significant role in the pathophysiology of various …

Objectives. In diabetes mellitus, hyperglycemia‐mediated nonenzymatic glycosylation of
fibrinogen protein plays a crucial role in the pathogenesis of micro‐and macrovascular …

Agents that inhibit glycation end products by reducing the carbonyl load from glycation and
glycoxidation are an emerging pharmacologic approach to treat complications of diabetes …

Autoreactivity is controlled at various steps by numerous mechanisms and is a key to
understanding and treating autoimmune disease. Recently, an antibody against deiminated …

Glycation is vital in terms of its damaging effect on macromolecules resulting in the formation
of end products, which are highly reactive and cross‐linked irreversible structures, known as …

Aims Glycation of proteins leads to the formation of advanced glycation end products (AGEs,
which have significant role in the pathophysiology of diabetes complications. d-ribose …